Teva stock drops 4.5% in spite of Q2 profit beat, revenue match

Teva stock drops 4.5% in spite of Q2 profit beat, revenue match

Source: 
Marketwatch
snippet: 

Teva Pharmaceutical Industries Ltd. TEVA, -9.91% shares dropped nearly 5% in Thursday premarket trade in spite of the company reporting a second-quarter profit beat and revenue match.